Nazende GündayTüreli retweeted
At Nano_GVA Symposium on October 5th in Geneva, @NazendeGT presented "PHOENIX Open Innovation Test Bed – New insight to advancing #nanopharmaceuticals" in a talk and podium discussion.
Thank you to the organizers for the enriching opportunity!
Nazende GündayTüreli retweeted
From March 27-28, we had a unique opportunity to attend the workshop “Accelerating Access to Medicines”, organized by partner @RCPE at the Austrian Embassy Washington @AustriainUSA.
@aetureli of @MyBiotechGmbH presented PHOENIX to an international audience.
#pharmaceuticals
Nazende GündayTüreli retweeted
📢OPEN CALL DEADLINE EXTENDED! 📢
Applications will be accepted until 28 February 2023 for funded services in #nanopharmaceutical development from our partners.
See updated info here: phoenix-oitb.eu/open-call/ & contact us with any questions! #GMP #manufacturing #nanomedicine
Nazende GündayTüreli retweeted
Bitte weiterverteilen! - Ich danke allen für die Unterstützung! lnkd.in/dVizGXV3
Are you looking for a great supervisor and mentor? Wanna be part of a leading team ? Then you should check @twan_lammers post 👇🏼
Postdoc, PhD and Technician positions available @UniklinikAachen and @RWTH. Join our diverse and dynamic team to work on translational aspects of cancer nanomedicine and nano-immunotherapy. Projects funded by @dfg_public and @ERC_Research. Contact via email or DM. Pls retweet 🙏
Don’t miss the joint stakeholders workshop of @phoenixoitb and @nano2clinic. Follow the link for registration 👇🏼
Attn industry, R&D&I sector, regulatory agencies, clinics, and patients! Save the date for our joint stakeholder workshop: "Nano2Clinic – Synergies for Clinical Translation of #Nanotechnology in #Cancer Therapies" on 3 March in #Zagreb.
phoenix-oitb.eu/nano-to-clin…
Nazende GündayTüreli retweeted
PHOENIX was featured in the latest @bionanonet QUARTERLY issue with an article about “Characterization of Nanomedicines to Ensure Pharmaceutical Quality, Speeding their Translation to the Clinics” by our partner @nanomoltech (pages 26-28).
Enjoy reading: phoenix-oitb.eu/phoenix-bnn-…
Nazende GündayTüreli retweeted
REMINDER!! Application deadline for the 2nd CA17140 Training School in Bellinzona (CH) is near - Deadline January 15, 2023
Interested participants are invited to use the registration form at nano2clinic.eu/news/upcoming… and follow the instructions there to submit their application.
Nazende GündayTüreli retweeted
Working on your application for our Open Call over the holidays?
In our Q&A, Scientific Coordinator @NazendeGT tells us about who should apply & what makes a great application.
We look forward to your submissions! phoenix-oitb.eu/phoenix-oitb… #OITB #GMP #scaleup #pharmaceutical
Nazende GündayTüreli retweeted
What are #liposomes and why do we use them for drug delivery? Find out more from this series #12DaysofNanomaterials bringing nanoparticles closer to the general public here:
@nanomoltech @icmabCSIC @leanbiopro
Lipid-based #nanoparticles can be functionalized to target certain areas of the body for drug delivery, making medications work more quickly and effectively in lower doses: “smart” drug delivery systems. They are well-tolerated and have lower toxicity than other nanoparticles. 💉
Nazende GündayTüreli retweeted
In our democase 5⃣@nanomoltech & @icmabCSIC are co-developing a potential nanomedicine for the topical treatment of microbial skin infections.
Within @phoenixoitb the #nanopharmaceutical will be scaled-up and manufactured under #GMP using DELOS nanoformulation technology. 👌
ALT https://www.phoenix-oitb.eu/demo-cases
Only two months before the submission deadline 🤭
OPEN CALL for funded services in #nanopharmaceutical development:
♦️Physico-Chemical, ♦️In vitro & ♦️In vivo Characterisation;
♦️Manufacturing
Legal entities & research groups based in 🇪🇺/#H2020 associate countries may apply.
Apply by 31 Jan 2023!
➡️phoenix-oitb.eu/open-call/
4
Nazende GündayTüreli retweeted
Dear COSTers,
the European Commission (EC) has recently opened Open Research Europe, the EC's fully open access publishing platform, to allow researchers on COST action projects to publish their results on this platform.
All info and links at: nano2clinic.eu/news/open-res…
Nazende GündayTüreli retweeted
Dear COSTers,
the recording of the MC meeting and the pdf of the presented slides are available on our website at: nano2clinic.eu/5th-mc-meetin…
Nazende GündayTüreli retweeted
The #CA17140 Final Conference will be held in Rome 🇮🇹 and concomitantly in #livestreaming for all of you who would like to join 📅 25-26 October 2022.
To access the event remotely, please follow the link: bit.ly/3goDe5J
Meeting ID: 367 473 789 776
Access code: JSW65J
Nazende GündayTüreli retweeted
It's #tbt to when @aetureli from @MyBiotechGmbH was in San Diego for the @DDF_Summit #DDFSummit Sept 26-27.
Our Open Call is now online - learn how you can benefit from PHOENIX services in #nanopharmaceutical development, from #benchtobedside.
phoenix-oitb.eu/open-call/
🔋Last coffee before the visitors 🔋
Visit @MyBiotechGmbH and @phoenixoitb at booth 669 @AAPS PharmsSci 360
#MyBiotech #PhoenixOITB #AAPS #PharmSci360
Hooorrrrraaaaay 🥳
OPEN CALL for funded services in #nanopharmaceutical development:
♦️Physico-Chemical, ♦️In vitro & ♦️In vivo Characterisation;
♦️Manufacturing
Legal entities & research groups based in 🇪🇺/#H2020 associate countries may apply.
Apply by 31 Jan 2023!
➡️phoenix-oitb.eu/open-call/
Spoiler Alert 🚨 open call on the way!! Soon, very soon 👇🏼
Visit PHOENIX at the @bionanonet booth at #BMT2022 to find out more about the project, browse our Service Portfolio and inform yourself about our upcoming Open Call!
bmt2022.at/
#OITB #nanopharmaceutical
ALT Table with flyers, business cards and portfolio, women speaking at table, project poster
4
👇🏼
Last week the PHOENIX consortium met @LIST_Luxembourg. Project coordinator Tomasso Serchi gave us a tour of the LIST facilities. Come along with us and see if you can spot...
-Confocal 🔬
-Enhanced Dark field hyperspectral🔬with confocal #RAMAN
-incubator for daphnia and algae
1